Jasper Therapeutics (JSPR)
(Real Time Quote from BATS)
$22.90 USD
-0.12 (-0.52%)
Updated May 20, 2024 03:26 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -1.07 |
EPS Last Quarter | -1.03 |
Last EPS Surprise | 18.25% |
ABR | 1.13 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.35 |
Next Year | -4.12 |
EPS (TTM) | -5.63 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 44.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 44.00M |
Low Estimate | NA | NA | NA | 44.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.07 | -1.14 | -4.35 | -4.12 |
# of Estimates | 5 | 4 | 6 | 5 |
Most Recent Consensus | -1.00 | -1.05 | -4.30 | -5.07 |
High Estimate | -0.96 | -0.98 | -3.82 | -2.44 |
Low Estimate | -1.19 | -1.27 | -4.82 | -5.08 |
Year ago EPS | -1.50 | -1.60 | -6.18 | -4.35 |
Year over Year Growth Est. | 28.67% | 28.75% | 29.61% | 5.24% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 2 | 5 | 4 |
Up Last 30 Days | 2 | 1 | 4 | 3 |
Up Last 60 Days | 2 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.07 | -1.14 | -4.35 | -4.12 |
7 Days Ago | -1.24 | -1.26 | -5.12 | -4.51 |
30 Days Ago | -1.18 | -1.19 | -5.00 | -4.34 |
60 Days Ago | -1.18 | -1.19 | -5.00 | -4.31 |
90 Days Ago | -1.60 | -1.60 | -6.00 | -5.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.07 | -1.10 | -4.46 | -4.12 |
Zacks Consensus Estimate | -1.07 | -1.14 | -4.35 | -4.12 |
Earnings ESP | 0.00% | 3.30% | -2.44% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.03 | -1.50 | -1.60 | -1.50 | NA |
Estimate | -1.26 | -1.65 | -1.50 | -1.30 | NA |
Difference | 0.23 | 0.15 | -0.10 | -0.20 | 0.02 |
Surprise | 18.25% | 9.09% | -6.67% | -15.38% | 1.32% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more